Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Multi-day Chemotherapy Nausea
NCT00711555Phase 2Completed
- Sponsor
- University of Illinois Chicago
- Start
- Nov 2005
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by University of Illinois Chicago. Started Nov 2005; status: completed.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00711555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711555.